Evaluation of the Safety of Virtual Visits After In-Clinic Botox® Injection: A Quality Improvement Study
International Urogynecology Journal · 2025
DOI: 10.1007/s00192-025-06216-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Urogynecology Journal, 2025. Verfasst von K Marie Douglass und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urogynecology & Reconstructive Pelvic Surgery, Department of OB/GYN, Harbor-UCLA Medical Center, 1000 W Carson Street, Torrance, CA, 9005…. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive, Botulinum Toxins, Type A, Telemedicine, Neuromuscular Agents. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION AND HYPOTHESIS: Virtual visits can be performed after in-clinic injection of Botox®, but data are lacking on the safety of these visits. The aim of this study was to evaluate the effects of a protocol change from in-person to virtual post-procedure visits after in-clinic injection of Botox®. METHODS: This was a quality improvement study that took place at a safety-net hospital. Initially, all patients undergoing Botox® injection for idiopathic overactive bladder were scheduled for a 2-week in-person assessment after their procedure. Beginning in January 2023, patients were instead scheduled for a 2-week phone visit where they were screened using standardized and validated questionnaires and asked to present for in-person assessment if they expressed worsening or concerning symptoms. Demographic variables, subjective improvement, need for in-person assessment, and rates of urinary tract infection and retention were compared between groups. RESULTS: Fifty-seven patients in the in-person-visit group and 60 in the phone-visit group were included. There was no difference in subjective improvement, symptoms of dysuria or incomplete emptying, or rates of urinary tract infection or retention between groups. Twenty-eight percent of patients who had phone visits were asked to return in-person, although this did not correspond with a higher rate of complications. The phone-visit group had a 68.3% reduction in face-to-face assessments overall when compared with the in-person group. CONCLUSIONS: Post-procedure phone visits are safe and feasible to perform after in-clinic Botox® injection, and are not associated with an increased risk of complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Urogynecology & Reconstructive Pelvic Surgery, Department of OB/GYN, Harbor-UCLA Medical Center, 1000 W Carson Street, Torrance, CA, 90052, USA. KDouglass2@dhs.lacounty.gov.
- Division of Urogynecology & Reconstructive Pelvic Surgery, Department of OB/GYN, Kaiser Permanente Dublin Medical Center, Dublin, CA, 94568, USA.
- Division of Urogynecology & Reconstructive Pelvic Surgery, Department of OB/GYN, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.
- Division of Urogynecology & Reconstructive Pelvic Surgery, Department of OB/GYN, Harbor-UCLA Medical Center, 1000 W Carson Street, Torrance, CA, 90052, USA.
ORCID-Profile: K Marie Douglass
Zitieren
APA
Douglass, K. M., Laus, K., DeAndrade, S., Whitaker, T., Yazdany, T., & Truong, C. (2025). Evaluation of the Safety of Virtual Visits After In-Clinic Botox® Injection: A Quality Improvement Study. International Urogynecology Journal. https://doi.org/10.1007/s00192-025-06216-9
Vancouver
Douglass KM, Laus K, DeAndrade S, Whitaker T, Yazdany T, Truong C. Evaluation of the Safety of Virtual Visits After In-Clinic Botox® Injection: A Quality Improvement Study. International Urogynecology Journal. 2025. doi:10.1007/s00192-025-06216-9
BibTeX
@article{Douglass2025,
author = {Douglass, K Marie and Laus, Katharina and DeAndrade, Samantha and Whitaker, Taylor and Yazdany, Tajnoos and Truong, Christina},
title = {Evaluation of the Safety of Virtual Visits After In-Clinic Botox® Injection: A Quality Improvement Study},
journal = {International Urogynecology Journal},
year = {2025},
doi = {10.1007/s00192-025-06216-9}
}
EUVIMED